Loss of Functional Suppression by CD4CD25 Regulatory T Cells in Patients with Multiple Sclerosis

Loss of Functional Suppression by CD4CD25 Regulatory T Cells in Patients with Multiple Sclerosis2018-01-17T17:06:22-05:00

A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study

A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study2018-01-17T17:05:56-05:00

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring

Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring2018-01-17T17:03:31-05:00

Inflammation and therapeutic vaccination in CNS diseases

Inflammation and therapeutic vaccination in CNS diseases2018-01-17T17:02:05-05:00

Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease

Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease2018-01-17T17:02:05-05:00

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response

Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response2018-01-17T16:59:56-05:00

IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production

IL-23 Is Increased in Dendritic Cells in Multiple Sclerosis and Down-Regulation of IL-23 by Antisense Oligos Increases Dendritic Cell IL-10 Production2018-01-17T16:59:38-05:00